PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryJan 15, 2014	Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien PLAINSBORO, N.J., Jan. 15, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of DuraSeal ® product lines from Covidien. Now, together with our DuraGen® family of grafts, Integra offers surgeons the largest	View HTML Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien 11.7 KB
Toggle SummaryJan 13, 2014	Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014 PLAINSBORO, N.J., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2013 financial results on Tuesday, February 25, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014 9.9 KB
Toggle SummaryDec 30, 2013	Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference PLAINSBORO, N.J., Dec. 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, Integra's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Mr.	View HTML Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference 10.5 KB
Toggle SummaryDec 23, 2013	Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Dec. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra ® Dermal Regeneration	View HTML Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers 13.2 KB
Toggle SummaryDec 12, 2013	Integra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery Compares Entubulation Versus Standard Microsurgical Technique for the Primary Repair of Median and Ulnar Nerve Injuries in the Forearm	View HTML
Toggle SummaryNov 18, 2013	Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December PLAINSBORO, N.J., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 12:00 PM ET on Tuesday, December 3, 2013, Mr. Peter Arduini, President and Chief Executive Officer of Integra	View HTML Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December 11.1 KB
Toggle SummaryNov 6, 2013	Integra LifeSciences Prices Public Offering of Common Stock PLAINSBORO, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has priced its previously announced underwritten public offering of 3,500,000 shares of its common stock at $40.00 per share.	View HTML Integra LifeSciences Prices Public Offering of Common Stock 13 KB
Toggle SummaryNov 4, 2013	Integra LifeSciences Announces Proposed Public Offering of Common Stock PLAINSBORO, N.J., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer, subject to market conditions and other factors, 3,500,000 shares of its common stock in an underwritten public offering registered under the	View HTML Integra LifeSciences Announces Proposed Public Offering of Common Stock 14 KB
Toggle SummaryOct 28, 2013	Integra LifeSciences Reports Third Quarter 2013 Financial Results Revenue In Line with Guidance Cash Flows from Operations of $31 Million PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2013.	View HTML Integra LifeSciences Reports Third Quarter 2013 Financial Results 52.5 KB
Toggle SummaryOct 28, 2013	Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has entered into a definitive agreement with Covidien to acquire the Confluent Surgical product lines, including surgical sealants, adhesion barrier, and, most importantly,	View HTML Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien 12.9 KB
Toggle SummaryOct 23, 2013	Integra LifeSciences Announces Update on Optimization Initiatives Plans Closure of Two Manufacturing Facilities Announces Additional Product Discontinuations Estimates Impairment to Goodwill in Spine Business PLAINSBORO, N.J., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to eliminate	View HTML Integra LifeSciences Announces Update on Optimization Initiatives 14.7 KB
Toggle SummaryOct 21, 2013	Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System Seamlessly Integrates With Camino(R) ICP Monitor	View HTML Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System 11.1 KB
Toggle SummaryOct 17, 2013	Integra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States Offers Surgeons Versatile Solution for Shoulder Fracture Treatment	View HTML Integra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States 10.3 KB
Toggle SummaryOct 11, 2013	Integra LifeSciences to Host Its Third Quarter 2013 Earnings Results Conference Call on October 28, 2013 PLAINSBORO, N.J., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2013 financial results on Monday, October 28, 2013. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Third Quarter 2013 Earnings Results Conference Call on October 28, 2013 9.8 KB
Toggle SummaryOct 10, 2013	Integra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System PLAINSBORO, N.J., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra ® Laminoplasty System, a comprehensive set of implants and instruments designed for use after open-door laminoplasty procedures in the cervical	View HTML Integra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System 10.4 KB